Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/7/2019
Schnucks expands curbside pickup to 59 stores
Schnucks’ curbside pickup service is now available at stores across Missouri, Illinois, and Indiana. - 11/6/2019
Mallinckrodt completes sale of BioVectra for up to $250M
The terms of Mallinckrodt's sale of BioVBectra were updated since it was initially announced, with the final total at nearly $250 million. - 11/6/2019
Teva, Celltrion launch their Rituxan biosimilar Truxima
Teva and Celltrion's Truxima is the first biosimilar to Genentech’s Rituxan (rituximab). - 11/6/2019
Hy-Vee to honor veterans with free breakfast, events
On Nov. 11, more than 90,000 meals are expected to be provided to veterans and active-duty military at more than 265 Hy-Vee stores. - 11/6/2019
Cardinal Health posts revenue growth in Q1
Cardinal Health’s first-quarter revenue was $33.4 billion. Despite being 6% greater than revenue in the same quarter last year, it was accompanied by a 3% drop in profit. - 11/5/2019
RedHill Biopharma gets FDA green light for Talicia
RedHill's Talicia is the first and only FDA approved rifabutin-based H. pylori infection therapy. - 11/4/2019
CVS Health, UPS make first residential drone deliveries of prescriptions
CVS has initiated residential drone delivery of prescriptions via UPS Flight Forward, from a CVS pharmacy in North Carolina. - 11/4/2019
Sandoz gets FDA green light for Neulasta biosimilar Ziextenzo
With the FDA approval of Ziextenzo — a biosimilar of Neulasta — Sandoz is the first and only company to offer long- and short-acting filgrastim biosimilar treatment options. - 11/4/2019
FDA approves Sanofi’s Fluzone High Dose Quadrivalent
Sanofi’s Fluzone High-Dose Quadrivalent is used in people age 65 and older, to protect against influenza A and B strains.
